An arthroscopy is a minimally invasive surgical procedure that is commonly used for the evaluation of knees and shoulders, but can also be used to examine and treat conditions of the wrist, ankle, and elbow. An arthroscopy is performed using an instrument called the arthroscope, which is essentially an endoscope with a tube length ranging from 110 mm to 187.5 mm. The tube has a camera attached and is inserted into a joint, through a small incision, for the examination and treatment of damaged interior joints.
Asia accounted for the 24.46% share of the arthroscope device market globally in 2013. The market value was pegged at $120.44 million in 2012 and is expected to register the highest growth rate of 7.7% from 2013 to 2018. Asian countries namely India and China are witnessing fast growth and are predicted to emerge as dominating markets in the near future. A rise in disposable incomes in these countries has boosted the confidence of OEMs towards these regions. Moreover investment friendly environment and low taxation is also encouraging the growth in these regions.
Companies are profoundly investing on R&D to come up with innovative products that are user friendly for the physicians. Moreover, to retain their market position companies are coming up innovative marketing strategies such as cross selling of arthroscopic products along with other orthopedic procedures. Rising disposable income, growing awareness of sports and favorable government policies has boosted the total growth of this market in Asia.
Minimally invasive procedures are rapidly replacing open surgeries as a result of technological innovations. Developments in visualization and monitoring equipment like arthroscopic devices for instance, have facilitated greater precision in joint and spinal surgeries by providing better image quality. For instance, the development of arthroscopes has not only lessened the size of surgical incisions required in a typical joint replacement or spinal fusion surgery, but has also dramatically reduced post-operative recovery time and hospital stays.
Some of the arthroscopes available in the market are Karl Storz 7210 CA ( Karl Storz GmbH & Co.), PENTEX ES 3870K SCOPE (Pentax Medical Company), and Olympus Arthroscope 2.7mm (Olympus Medical System Corporation).
The market is segmented and forecasted on the basis of major countries, such as, India, China and Japan. The report provides an extensive competitive landscaping of companies operating in this market. The key players of the market covered in the report are Olympus Medical Systems Corporation, Karl Storz, Covidien Plc, Richard Wolf, Stryker Corporation, Pentax Medical Company. This report also includes the market share, value chain analysis, and market metrics such as drivers, restraints and upcoming opportunities in the market.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE | PUBLISHED | |
---|---|---|
North American Rigid Endoscopes Market The North American Rigid Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $1.03billion in 2013 and expected to be $1.41 billion by 2018, growing at a CAGR of 6.5%. The Endoscopes Market analyzes the market segments such as Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming | |
European Rigid Endoscopes Market The European Rigid Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $0.66 billion in 2013 and expected to be $0.86 billion by 2018, growing at a CAGR of 5.4%. The Endoscopes Market analyzes the market segments such as Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming | |
Asian Rigid Endoscopes Market The Asian Rigid Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $0.61 billion in 2013 and expected to be $0.86 billion by 2018, growing at a CAGR of 7.2%. The Endoscopes Market analyzes the market segments such as Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |